Eying Its Subsequent Blockbuster, Astellas Traces Up $5.9B Iveric Bio Acquisition
Astellas Pharma is trying to find medication to make up for the decline in income going through its top-selling product...
Eying
Astellas Pharma is trying to find medication to make up for the decline in income going through its top-selling product...
